1
|
Overexpression of T-bet, GATA-3 and TGF-ß Induces IFN-γ, IL-4/13A, and IL-17A Expression in Atlantic Salmon. BIOLOGY 2020; 9:biology9040082. [PMID: 32326041 PMCID: PMC7235720 DOI: 10.3390/biology9040082] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Revised: 04/13/2020] [Accepted: 04/15/2020] [Indexed: 11/16/2022]
Abstract
The overexpression of GATA-3, T-bet and TGF-ß may theoretically induce IL-4/A, IFN-γ and IL-17A expression, respectively. Whether this also applies to fish is not yet known. The plasmid vectors encoding reporter gene (RFP)-tagged T-bet, GATA-3 and TGF-ß were used as overexpression tools, transfected into cells or injected intramuscularly to monitor the expression of IFN-γ, IL-4/13A and IL-17A. In addition, the fish were either experimentally challenged with Vibrio anguillarum (VA group) or Piscirickettsia salmonis (PS group). The reporter gene (RFP) inserted upstream of the GATA-3, T-bet and TGF-ß genes, was observed in muscle cell nuclei and in inflammatory cells after intramuscular (i.m.) injection. PS group: following the injection of GATA-3 and T-bet-encoding plasmids, the expression of GATA-3 and T-bet was high at the injection site. The spleen expression of IFN-γ, following the injection of a T-bet-encoding plasmid, was significantly higher on day 2. VA group: The T-bet and GATA-3-overexpressing fish expressed high T-bet and GATA-3 mRNA levels in the muscles and on day 4 post-challenge. The expression of TGF-ß in the muscles of fish injected with TGF-ß-encoding plasmids was significantly higher on days 7 (8 days pre-challenge) and 19 (4 days after challenge). The protective effects of the overexpression of T-bet, GATA-3 and TGF-ß on both bacterial infections were negligible.
Collapse
|
2
|
Gao Y, Pei C, Sun X, Zhang C, Li L, Kong X. Plasmid pcDNA3.1- s11 constructed based on the S11 segment of grass carp reovirus as DNA vaccine provides immune protection. Vaccine 2018; 36:3613-3621. [DOI: 10.1016/j.vaccine.2018.05.043] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2017] [Revised: 05/01/2018] [Accepted: 05/07/2018] [Indexed: 01/12/2023]
|
3
|
A plant 35S CaMV promoter induces long-term expression of luciferase in Atlantic salmon. Sci Rep 2016; 6:25096. [PMID: 27114167 PMCID: PMC4844988 DOI: 10.1038/srep25096] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Accepted: 03/30/2016] [Indexed: 11/08/2022] Open
Abstract
The long-term persistence and activity of a naked plasmid DNA (pGL3-35S) containing a luc gene (reporter gene) controlled by a plant 35S CaMV promoter was studied in Atlantic salmon (Salmo salar L.) after injection. Atlantic salmon (mean weight 70 grams) were injected intramuscularly with 100 μg of plasmid DNA. Blood, different tissues and organs were sampled at different time points up to day 535 after injection. Southern blot analysis suggested the presence of extra-chromosomally open circular, linear and supercoiled topoforms of pGL3-35S at day 150 after injection. At day 536 open circular and supercoiled topoforms were detected. Luciferase activity was detected at the injection site up to 536 days post-injection of pGL3-35S, where it peaked at day 150 and decreased to approximately 17% of its maximum activity by day 536. Our study demonstrated that a plasmid containing the 35S promoter was able to induce expression of a reporter gene/protein in fish in vivo and that the plasmid DNA persisted for a prolonged time after intramuscular injection.
Collapse
|
4
|
Chaudhari A, Pathakota GB, Annam PK. Design and Construction of Shrimp Antiviral DNA Vaccines Expressing Long and Short Hairpins for Protection by RNA Interference. Methods Mol Biol 2016; 1404:225-240. [PMID: 27076302 DOI: 10.1007/978-1-4939-3389-1_16] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
DNA vaccines present the aquaculture industry with an effective and economically viable method of controlling viral pathogens that drastically affect productivity. Since specific immune response is rudimentary in invertebrates, the presence of RNA interference (RNAi) pathway in shrimps provides a promising new approach to vaccination. Plasmid DNA vaccines that express short or long double stranded RNA in vivo have shown protection against viral diseases. The design, construction and considerations for preparing such vaccines are discussed.
Collapse
Affiliation(s)
- Aparna Chaudhari
- ICAR-Central Institute of Fisheries Education, Versova, Andheri West, Mumbai, 400061, India.
| | - Gireesh-Babu Pathakota
- ICAR-Central Institute of Fisheries Education, Versova, Andheri West, Mumbai, 400061, India
| | - Pavan-Kumar Annam
- ICAR-Central Institute of Fisheries Education, Versova, Andheri West, Mumbai, 400061, India
| |
Collapse
|
5
|
Abstract
Hydrodynamic delivery (HD) is a broadly used procedure for DNA and RNA delivery in rodents, serving as a powerful tool for gene/protein drug discovery, gene function analysis, target validation, and identification of elements in regulating gene expression in vivo. HD involves a pressurized injection of a large volume of solution into a vasculature. New procedures are being developed to satisfy the need for a safe and efficient gene delivery in clinic. Here, we summarize the fundamentals of HD, its applications, and future perspectives for clinical use.
Collapse
Affiliation(s)
- Takeshi Suda
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
| | - Dexi Liu
- Department of Pharmaceutical and Biomedical Sciences, University of Georgia, School of Pharmacy, Athens, GA, USA
| |
Collapse
|
6
|
Ruyra A, Cano-Sarabia M, García-Valtanen P, Yero D, Gibert I, Mackenzie SA, Estepa A, Maspoch D, Roher N. Targeting and stimulation of the zebrafish (Danio rerio) innate immune system with LPS/dsRNA-loaded nanoliposomes. Vaccine 2014; 32:3955-62. [PMID: 24837767 DOI: 10.1016/j.vaccine.2014.05.010] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2014] [Revised: 04/25/2014] [Accepted: 05/01/2014] [Indexed: 02/08/2023]
Abstract
Herein we report the use of immunostimulant-loaded nanoliposomes (called NLcliposomes) as a strategy to protect fish against bacterial and/or viral infections. This work entailed developing a method for in vivo tracking of the liposomes administered to adult zebrafish that enables evaluation of their in vivo dynamics and characterisation of their tissue distribution. The NLc liposomes, which co-encapsulate poly(I:C) and LPS, accumulate in immune tissues and in immunologically relevant cells such as macrophages, as has been assessed in trout primary cell cultures. They protect zebrafish against otherwise lethal bacterial (Pseudomonas aeruginosa PAO1) and viral (Spring Viraemia of Carp Virus) infections regardless of whether they are administered by injection or by immersion, as demonstrated in a series of in vivo infection experiments with adult zebrafish. Importantly, protection was not achieved in fish that had been treated with empty liposomes or with a mixture of the free immunostimulants. Our findings indicate that stimulation of the innate immune system with co-encapsulated immunostimulants in nano-liposomes is a promising strategy to simultaneously improve the levels of protection against bacterial and viral infections in fish.
Collapse
Affiliation(s)
- Angels Ruyra
- Institut de Biotecnologia i de Biomedicina - Parc de Recerca UAB and Dep. de Biologia Cellular, Immunologia i Fisiologia Animal, Universitat Autònoma de Barcelona, Bellaterra, Spain
| | - Mary Cano-Sarabia
- ICN2 - Institut Català de Nanociència i Nanotecnologia, Campus UAB, 08193 Bellaterra, Barcelona, Spain
| | - Pablo García-Valtanen
- Instituto de Biología Celular y Molecular, Universidad Miguel Hernandez, Elche, Spain
| | - Daniel Yero
- Institut de Biotecnologia i de Biomedicina - Parc de Recerca UAB and Dep. de Biologia Cellular, Immunologia i Fisiologia Animal, Universitat Autònoma de Barcelona, Bellaterra, Spain; Dep. de Genètica i Microbiologia, Universitat Autònoma de Barcelona
| | - Isidre Gibert
- Institut de Biotecnologia i de Biomedicina - Parc de Recerca UAB and Dep. de Biologia Cellular, Immunologia i Fisiologia Animal, Universitat Autònoma de Barcelona, Bellaterra, Spain; Dep. de Genètica i Microbiologia, Universitat Autònoma de Barcelona
| | - Simon A Mackenzie
- Institute of Aquaculture, University of Stirling, Stirling, Scotland, UK
| | - Amparo Estepa
- Instituto de Biología Celular y Molecular, Universidad Miguel Hernandez, Elche, Spain
| | - Daniel Maspoch
- ICN2 - Institut Català de Nanociència i Nanotecnologia, Campus UAB, 08193 Bellaterra, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08100 Barcelona, Spain
| | - Nerea Roher
- Institut de Biotecnologia i de Biomedicina - Parc de Recerca UAB and Dep. de Biologia Cellular, Immunologia i Fisiologia Animal, Universitat Autònoma de Barcelona, Bellaterra, Spain.
| |
Collapse
|
7
|
Wolf A, Hodneland K, Frost P, Hoeijmakers M, Rimstad E. Salmonid alphavirus-based replicon vaccine against infectious salmon anemia (ISA): impact of immunization route and interactions of the replicon vector. FISH & SHELLFISH IMMUNOLOGY 2014; 36:383-392. [PMID: 24374059 DOI: 10.1016/j.fsi.2013.12.018] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2013] [Revised: 11/26/2013] [Accepted: 12/18/2013] [Indexed: 06/03/2023]
Abstract
A salmonid alphavirus (SAV)-based replicon encoding the infectious salmon anemia virus (ISAV) hemagglutinin-esterase (HE), pSAV/HE, is an efficacious vaccine against infectious salmon anemia (ISA). Delivered intramuscularly (i.m.), the replicon vaccine provides high protection against subsequent ISAV challenge in Atlantic salmon (Salmo salar), and induces a strong innate response locally at the injection site. This may be beneficial and could warrant reduced doses and improved efficacy compared to conventional DNA vaccines. In the present study, we found that intraperitoneal (i.p.) administration of the pSAV/HE replicon vaccine did not induce protection, neither alone or in combination with a sub-potent, inactivated low-dose ISAV vaccine given i.p. No significant differences between the two immunization routes regarding systemic immune responses could be observed. I.m. injection of the replicon vector encoding a non-viral gene or the protective glycoprotein (G protein) from the heterologous viral hemorrhagic septicemia virus (VHSV) induced no protection against ISA. Although the replicons without the ISAV HE did induce IFN-signaling pathways at the muscle injection site similar to the pSAV/HE replicon they did not improve the efficacy of a sub-potent inactivated low-dose ISAV vaccine delivered i.p. Moreover, there was a tendency for reduced efficacy of the pSAV/HE replicon vaccine injected i.m. when co-injected with the replicon encoding the VHSV G protein, which previously, after DNA vaccination, have been reported to induce cross-protection against heterologous virus challenge in fish.
Collapse
Affiliation(s)
- Astrid Wolf
- Department of Food Safety and Infection Biology, The Norwegian School of Veterinary Science, P.O. 8146 Dep, N-0033 Oslo, Norway.
| | - Kjartan Hodneland
- MSD Animal Health Innovation AS, Thormøhlensgate 55, N-5008 Bergen, Norway.
| | - Petter Frost
- MSD Animal Health Innovation AS, Thormøhlensgate 55, N-5008 Bergen, Norway.
| | | | - Espen Rimstad
- Department of Food Safety and Infection Biology, The Norwegian School of Veterinary Science, P.O. 8146 Dep, N-0033 Oslo, Norway.
| |
Collapse
|
8
|
Evensen Ø, Leong JAC. DNA vaccines against viral diseases of farmed fish. FISH & SHELLFISH IMMUNOLOGY 2013; 35:1751-8. [PMID: 24184267 DOI: 10.1016/j.fsi.2013.10.021] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2013] [Revised: 10/22/2013] [Accepted: 10/22/2013] [Indexed: 05/12/2023]
Abstract
Immunization by an antigen-encoding DNA was approved for commercial sale in Canada against a Novirhabdovirus infection in fish. DNA vaccines have been particularly successful against the Novirhabdoviruses while there are reports on the efficacy against viral pathogens like infectious pancreatic necrosis virus, infectious salmon anemia virus, and lymphocystis disease virus and these are inferior to what has been attained for the novirhabdoviruses. Most recently, DNA vaccination of Penaeus monodon against white spot syndrome virus was reported. Research efforts are now focused on the development of more effective vectors for DNA vaccines, improvement of vaccine efficacy against various viral diseases of fish for which there is currently no vaccines available and provision of co-expression of viral antigen and immunomodulatory compounds. Scientists are also in the process of developing new delivery methods. While a DNA vaccine has been approved for commercial use in farmed salmon in Canada, it is foreseen that it is still a long way to go before a DNA vaccine is approved for use in farmed fish in Europe.
Collapse
Affiliation(s)
- Øystein Evensen
- Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, PO Box 8146 Dep., N-0033 Oslo, Norway.
| | | |
Collapse
|
9
|
de las Heras AI, Rodríguez Saint-Jean S, Pérez-Prieto SI. Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish. FISH & SHELLFISH IMMUNOLOGY 2010; 28:562-70. [PMID: 20034576 DOI: 10.1016/j.fsi.2009.12.006] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2009] [Revised: 12/10/2009] [Accepted: 12/12/2009] [Indexed: 05/12/2023]
Abstract
DNA vaccines and oral DNA-based immunotherapy against infectious pancreatic necrosis virus (IPNV) have scarcely been studied in salmonid fish. Here, a vector with the capsid VP2 gene inserted was encapsulated in alginate microspheres to avoid the aggressive gastrointestinal conditions experienced following oral administration. Alginate microspheres were effective to protect the pDNA encoding VP2, which was expressed early in different organs of the vaccinated trout and that persisted for at least 60 days. The vaccine induces innate immune responses, raising the expression of IFN more than 10-fold relative to the fish vaccinated with the empty plasmid, at 7 and 15 days post-vaccination. Likewise, maximal expression of the IFN-induced antiviral Mx protein was recorded 15 days post-vaccination and neutralizing antibodies were also detected after 15 days, although their titre rose further at 21 days post-vaccination. Protection was high in the immunized fish, which showed around an 80% relative survival when challenged 15 and 30 days after vaccine delivery. Very low viral load with respect to the control group was detected in the vaccinated fish that survived 45 days after challenge. Thus, this study demonstrates the potential of the encapsulation technique for IPNV-DNA vaccine delivery and the relevance of the IPNV-VP2 gene for future plasmid constructs.
Collapse
Affiliation(s)
- Ana I de las Heras
- Centro de Investigaciones Biológicas, Departamento de Microbiología Molecular y Biología de las Infecciones, C/Ramiro de Maeztu 9, 28040 Madrid, Spain
| | | | | |
Collapse
|
10
|
Abstract
Improving the transfection efficiencies of nonviral gene delivery requires properly engineered nanoscaled delivery carriers that can overcome the multiple barriers associated with the delivery of oligonucleotides from the site of administration to the nucleus or cytoplasm of the target cell. This article reviews the current advantages and limitation of polyplex nonviral delivery systems, including the apparent barriers that limit gene expression efficiency compared to physical methods such as hydrodynamic dosing and electroporation. An emphasis is placed on engineered nanoscaled polyplexes (NSPs) of modular design that both self-assemble and systematically disassemble at the desired stage of delivery. It is suggested that NSPs of increasingly sophisticated designs are necessary to improve the efficiency of the rate limiting steps in gene delivery.
Collapse
Affiliation(s)
- Christian A Fernandez
- Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, USA
| | | |
Collapse
|
11
|
Tonheim TC, Bøgwald J, Dalmo RA. What happens to the DNA vaccine in fish? A review of current knowledge. FISH & SHELLFISH IMMUNOLOGY 2008; 25:1-18. [PMID: 18448358 DOI: 10.1016/j.fsi.2008.03.007] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/12/2007] [Revised: 03/11/2008] [Accepted: 03/12/2008] [Indexed: 05/12/2023]
Abstract
The primary function of DNA vaccines, a bacterial plasmid DNA containing a construct for a given protective antigen, is to establish specific and long-lasting protective immunity against diseases where conventional vaccines fail to induce protection. It is acknowledged that less effort has been made to study the fate, in terms of cellular uptake, persistence and degradation, of DNA vaccines after in vivo administration. However, during the last year some papers have given new insights into the fate of DNA vaccines in fish. By comparing the newly acquired information in fish with similar knowledge from studies in mammals, similarities with regard to transport, blood clearance, cellular uptake and degradation of DNA vaccines have been found. But the amount of DNA vaccine redistributed from the administration site after intramuscular administration seems to differ between fish and mammals. This review presents up-to-date and in-depth knowledge concerning the fate of DNA vaccines with emphasis on tissue distribution, cellular uptake and uptake mechanism(s) before finally describing the intracellular hurdles that DNA vaccines need to overcome in order to produce their gene product.
Collapse
Affiliation(s)
- Tom Christian Tonheim
- Department of Marine Biotechnology, The Norwegian College of Fishery Science, University of Tromsø, N-9037 Tromsø, Norway.
| | | | | |
Collapse
|
12
|
Tonheim TC, Dalmo RA, Bøgwald J, Seternes T. Specific uptake of plasmid DNA without reporter gene expression in Atlantic salmon (Salmo salar L.) kidney after intramuscular administration. FISH & SHELLFISH IMMUNOLOGY 2008; 24:90-101. [PMID: 18023591 DOI: 10.1016/j.fsi.2007.09.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/15/2007] [Revised: 09/24/2007] [Accepted: 09/26/2007] [Indexed: 05/12/2023]
Abstract
In this study we investigated tissue distribution of pDNA after intramuscular and intravenous administration, cellular localisation, receptor-specific uptake, integrity of pDNA and transgene expression in Atlantic salmon (Salmo salar L). Anatomical distribution of plasmid DNA was determined using both radiotracing and fluorescence microscopy. Cellular uptake was studied in cultures of adherent anterior kidney leucocytes. The integrity of the pDNA in vivo was investigated by Southern blot analysis. Transcription of plasmid DNA encoded luciferase gene and protein synthesis were investigated in salmon tissues by means of real-time reverse transcription-polymerase chain reaction and enzyme activity measurements, respectively. Approximately 50% of the total recovered radioactivity was redistributed from the carcass 168h after intramuscular administration and accumulated mainly in the kidneys (37% of total). The majority of radiolabelled plasmid DNA administered intravenously was taken up within the first 15min mainly by the kidney. Intravenous co-administration of trace amounts of radiolabelled plasmid DNA with excess amounts of unlabelled plasmid DNA or formaldehyde treated albumin (a ligand for the scavenger receptors) significantly inhibited accumulation of the radiotracer in the kidney. Fluorescence microscopy demonstrated that fluorescence was localised intracellularly in cells lining the sinusoids of the kidney after intravenous administration of rhodamine-labelled plasmid DNA. Southern blot analysis demonstrated presence of supercoiled plasmid DNA in all organs and tissue samples 168h after intramuscular administration, but degradation products were only revealed at the administration site. Luciferase transcript and activity were only detectable at the administration site 24-168h after intramuscular administration of plasmid DNA. After incubation with trace amounts of radiolabelled plasmid DNA, only minor amounts of radiolabelled plasmid DNA were cell associated in cultures of adherent anterior kidney leucocytes. These results suggested that a substantial portion of radiolabelled plasmid DNA was redistributed from the carcass and was mainly cleared by a receptor-specific uptake in the kidney. Although intact plasmid DNA was detected in the kidney and other tissues, no luciferase transcripts or activity were detected in these samples at any time points investigated (24-168h), except for the administration site following intramuscular administration.
Collapse
Affiliation(s)
- Tom Christian Tonheim
- Department of Marine Biotechnology, The Norwegian College of Fishery Science, University of Tromsø, N-9037 Tromsø, Norway.
| | | | | | | |
Collapse
|
13
|
Abstract
Efficient and safe methods for delivering genetic materials into cells must be developed before the clinical potential of gene therapy can be fully realized. Recently, hydrodynamic gene delivery using a rapid injection of a relatively large volume of DNA solution has opened up a new avenue for gene therapy studies in vivo. This method is superior to the existing delivery systems because of its simplicity, efficiency, and versatility. Wide success in applying hydrodynamic principles to delivery of DNA, RNA, proteins, and synthetic compounds, into the cells in various tissues of small animals, has inspired the recent attempts at establishing a hydrodynamic procedure for clinical use. In this review, we provide an overview of the theory and practice of hydrodynamic gene delivery so as to aid researchers for the use of this method in their pre-clinical and translational gene therapy studies.
Collapse
Affiliation(s)
- Takeshi Suda
- 1Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15261, USA
| | | |
Collapse
|
14
|
Tan CW, Jesudhasan P, Woo PTK. Towards a metalloprotease-DNA vaccine against piscine cryptobiosis caused by Cryptobia salmositica. Parasitol Res 2007; 102:265-75. [PMID: 17932691 DOI: 10.1007/s00436-007-0757-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2007] [Accepted: 09/18/2007] [Indexed: 11/25/2022]
Abstract
Cysteine protease is a metabolic enzyme, whereas metalloprotease is the virulent factor in cryptobiosis caused by Cryptobia salmositica. Recombinant DNA vaccines were produced with the insertion of either the metalloprotease or cysteine protease gene of C. salmositica into plasmid vectors (pEGFP-N). As expected, fishes (Oncorhynchus mykiss and Salmo salar) injected intramuscularly with the metalloprotease-DNA (MP-DNA) vaccine (50 microg/fish) were consistently more anemic (lower packed cell volume, PCV) than controls (injected only with the plasmid) at 3-5 weeks post-inoculation. Also, there were no difference in PCV between fish injected with the cysteine-DNA plasmids and the controls. In addition, agglutinating antibodies against Cryptobia were detected only in the blood of MP-DNA-vaccinated fish at 5-7 weeks post-vaccination and not in cysteine-DNA plasmids and the control groups. MP-DNA-vaccinated fish when challenged with the pathogen had consistently lower parasitemia, delayed peak parasitemia, and faster recovery compared with the controls. All fish vaccinated with attenuated strain were protected when challenged with the pathogen; this positive control group confirmed that the two vaccines operate through different mechanisms.
Collapse
Affiliation(s)
- Chung-Wei Tan
- Department of Integrative Biology, University of Guelph, Guelph, Ontario, Canada
| | | | | |
Collapse
|
15
|
Tonheim TC, Leirvik J, Løvoll M, Myhr AI, Bøgwald J, Dalmo RA. Detection of supercoiled plasmid DNA and luciferase expression in Atlantic salmon (Salmo salar L.) 535 days after injection. FISH & SHELLFISH IMMUNOLOGY 2007; 23:867-76. [PMID: 17502156 DOI: 10.1016/j.fsi.2007.03.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2007] [Revised: 03/26/2007] [Accepted: 03/27/2007] [Indexed: 05/12/2023]
Abstract
In this study our aim was to investigate the persistence and distribution of plasmid DNA in Atlantic salmon. Atlantic salmon (mean weight 70 g) were injected with 100 microg of plasmid DNA in 100 microl of phosphate buffered saline. The fish were reared in running fresh water at temperature 0-12 degrees C and injections were performed at 8 degrees C. After intramuscular injection, samples were obtained from blood and different tissues and organs up to day 535 after injection. We found by use of Southern blotting open circular and supercoiled plasmid DNA at the injection site and plasmid DNA fragments, assessed by real-time PCR, were detected in some of the examined tissues up to day 535. A co-persistence of luciferase transcript and activity were identified at the injection site up to day 535, however analysis of DAM methylation pattern suggested that the plasmid DNA did not replicate in vivo. Our study indicated that the plasmid DNA can persist for a prolonged time after intramuscular injection.
Collapse
Affiliation(s)
- Tom Christian Tonheim
- Department of Marine Biotechnology, The Norwegian College of Fishery Science, University of Tromsø, N-9037, Tromsø, Norway.
| | | | | | | | | | | |
Collapse
|
16
|
Schyth BD, Lorenzen N, Pedersen FS. A high throughput in vivo model for testing delivery and antiviral effects of siRNAs in vertebrates. Mol Ther 2007; 15:1366-72. [PMID: 17505484 DOI: 10.1038/sj.mt.6300150] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Despite the promise of small interfering RNAs (siRNAs) in antiviral therapy, few in vivostudies of them as inhibitors of viral replication and disease have been published, a lack that is most probably due to problems with obtaining successful delivery. Here we introduce a novel in vivomodel composed of small juvenile rainbow trout and a fish pathogenic virus to analyze the delivery and antiviral effects of formulated siRNAs. Intraperitoneally (IP) injected siRNAs formulated in polycationic liposomes, and to a lesser degree naked siRNAs, primarily entered free IP cells, including macrophage-like cells. Uptake in these cells correlated with antiviral activity, seen as reduced mortality of virus-challenged fish. However, protection at the disease level was not dependent upon which of three tested siRNAs was used, and protection correlated with up-regulation of an interferon (IFN)-related gene in the liver, indicating a systemic IFN response. The results emphasize the compromise in using transfection reagents for improved uptake of siRNAs, where these reagents also increase the risk of the siRNAs ending up in a cellular compartment in which stimulation of non-specific anti-viral defence mechanisms will be initiated.
Collapse
Affiliation(s)
- Brian Dall Schyth
- National Veterinary Institute, Technical University of Denmark, Arhus N., Denmark.
| | | | | |
Collapse
|
17
|
Persistence and distribution of intravenously injected DNA in blood and organs of Atlantic salmon (Salmo salar L.). Eur Food Res Technol 2005. [DOI: 10.1007/s00217-005-0101-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
18
|
Abstract
Strategies for gene delivery comprise a diverse range of live and synthetic approaches; DNA delivery for the purposes of immunisation in turn comprises a large part of this research. This review mainly discusses synthetic systems for application in the delivery of plasmid DNA vaccines, outlining polylactide-co-glycolide, liposome, chitosan and complex combination delivery systems. Areas of promise for DNA vaccine candidates include immune modulation of allergic responses and veterinarian application. The potential for realistic consideration of DNA vaccines as an alternative to existing approaches is dependent on the development of efficient DNA vaccine vectors and improved systems for DNA vaccine delivery. DNA vaccine technology may yet prove to be an important asset in an environment where there is a critical need for therapeutic and prophylactic strategies to combat a wide range of disease states.
Collapse
Affiliation(s)
- H Oya Alpar
- University of London, School of Pharmacy, UK.
| | | | | |
Collapse
|
19
|
Romøren K, Thu BJ, Bols NC, Evensen Ø. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2004; 1663:127-34. [PMID: 15157615 DOI: 10.1016/j.bbamem.2004.02.007] [Citation(s) in RCA: 84] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2003] [Revised: 01/20/2004] [Accepted: 02/27/2004] [Indexed: 11/24/2022]
Abstract
The transfection efficiency of liposome-based DNA formulations was studied in different salmonid cell lines of hepatocyte and macrophage origin. Parallel assessment of cell viability was carried out to define the balance between transfection efficiency and toxicity. For all cell lines, transfection efficiency varied with the lipoplex charge ratio and the amount of DNA added to the liposomes. The hepatocyte-derived cell line was most readily transfected while lower transfection efficiency was observed for the macrophage cell lines. The cationic liposomes showed a dose-dependent toxicity and were found to be most toxic for cells of macrophage origin. This was in line with the observation that higher amounts of lipids were associated with the cells of macrophage origin than the hepatocytes. Complexing DNA with the liposomes reduced the toxicity for all three cell lines, most markedly, however, for macrophage cell lines. The differences in the transfection and toxicity patterns between the cell lines are probably caused by differences in membrane composition as well as differences in phagocytic activity and processing of the liposomes/lipoplexes.
Collapse
Affiliation(s)
- Kristine Romøren
- Department of Pharmaceutics, School of Pharmacy, University of Oslo, Norway
| | | | | | | |
Collapse
|